Beats Medical Group is a leading brand in the field of digital therapeutics, offering tailored solutions for central nervous system (CNS) conditions and rare diseases. With their state-of-the-art Colbolt© platform, they provide patients with objective assessments and proven therapies, all through smartphone applications without the need for additional hardware. Their platform utilizes advanced AI and ML technology to accurately evaluate symptoms and create personalized therapeutic programs to address each individual's specific needs.

By unlocking the potential of digital biomarkers, Beats Medical is revolutionizing decision-making and patient engagement throughout the healthcare journey, leading to better outcomes for all. Beats Medical is proud to collaborate with industry-leading partners to further enhance their understanding and treatment of patients with CNS and rare conditions. With a strong focus on multi-symptom management, engaging user interface, precision tailoring, and daily accessibility, their commercialized solutions, including the award-winning Parkinson's Therapy App and Dyspraxia app, provide effective support and therapies for patients across different age groups.

Backed by regulatory approval, high effectiveness, usability, and technical stability, Beats Medical is dedicated to improving the lives of patients worldwide, making them a trusted choice in the digital therapeutics space